Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

More articles from Articles

  • You have accessRestricted Access
    Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
    Carlos Chiurchiu, Giuseppe Remuzzi and Piero Ruggenenti
    JASN March 2005, 16 (3 suppl 1) S58-S63; DOI: https://doi.org/10.1681/ASN.2004110968
    Add to Selected Citations
  • You have accessRestricted Access
    Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
    Julián Segura, José A. García-Donaire and Luis M. Ruilope
    JASN March 2005, 16 (3 suppl 1) S64-S66; DOI: https://doi.org/10.1681/ASN.2004110969
    Add to Selected Citations
  • You have accessRestricted Access
    Epoetin-Induced Autoimmune Pure Red Cell Aplasia
    Nicole Casadevall, Kai-Uwe Eckardt and Jérôme Rossert
    JASN March 2005, 16 (3 suppl 1) S67-S69; DOI: https://doi.org/10.1681/ASN.2004110959
    Add to Selected Citations
  • You have accessRestricted Access
    Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No
    Alberto Morganti
    JASN March 2005, 16 (3 suppl 1) S70-S73; DOI: https://doi.org/10.1681/ASN.2004110964
    Add to Selected Citations
  • You have accessRestricted Access
    Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?
    Giuseppe Mancia and Guido Grassi
    JASN March 2005, 16 (3 suppl 1) S74-S77; DOI: https://doi.org/10.1681/ASN.2004110963
    Add to Selected Citations
  • You have accessRestricted Access
    Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
    Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani and Paola Fioretto
    JASN March 2005, 16 (3 suppl 1) S78-S82; DOI: https://doi.org/10.1681/ASN.2004110961
    Add to Selected Citations
  • You have accessRestricted Access
    Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
    Giovanni Tripepi, Francesca Mallamaci and Carmine Zoccali
    JASN March 2005, 16 (3 suppl 1) S83-S88; DOI: https://doi.org/10.1681/ASN.2004110972
    Add to Selected Citations
  • You have accessRestricted Access
    Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
    Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari and Roberto Pontremoli
    JASN March 2005, 16 (3 suppl 1) S89-S91; DOI: https://doi.org/10.1681/ASN.2004110956
    Add to Selected Citations
  • You have accessRestricted Access
    Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
    Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi and Giacomo Deferrari
    JASN March 2005, 16 (3 suppl 1) S48-S52; DOI: https://doi.org/10.1681/ASN.2004110957
    Add to Selected Citations
  • You have accessRestricted Access
    Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
    Liffert Vogt, Gerjan Navis and Dick de Zeeuw
    JASN March 2005, 16 (3 suppl 1) S53-S57; DOI: https://doi.org/10.1681/ASN.2004121074
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire